Saramin Q1 Operating Profit Doubles, Cancels Treasury Shares
-
Consolidated Q1: Revenue ₩28,293M (+0.9% YoY), Operating profit ₩4,269M (+117%), Net profit ₩5,021M
-
Shareholder return: 976,532 treasury shares cancelled, remaining 234,000 shares (acquisition cost ₩3,569M)
-
2025 year-end dividend paid: ₩7,349M (up from ₩5,249M prior year)
-
Subsidiary Saramin Lab (㈜라라잡) merger completed (Feb 2026)
-
One pending lawsuit (₩52M), immaterial financial impact
-
R&D expense ₩2,749M (9.72% of revenue)
KOSDAQ Filing Information
-
Filing: Quarterly Report (2026.03)
-
Company: Saramin (143240)
-
Submission: Saramin Co., Ltd.
-
Receipt: 05-14-2026